Innovex International, Inc.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
INVX$25.32+0.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| (in thousands, except share and par value amounts) | December 31,2025 | December 31,2024 |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and restricted cash | $203,407 | $73,278 |
| Trade receivables, net of allowance of $19,752 and $63,875 at December 31, 2025 and December 31, 2024, respectively | 237,774 | 239,506 |
| Contract assets | 2,705 | 5,062 |
| Inventories | 248,433 | 271,173 |
| Assets held for sale | — | 4,749 |
| Prepaid expenses and other current assets | 35,728 | 47,623 |
| Total current assets | 728,047 | 641,391 |
| Noncurrent assets | ||
| Property and equipment, net | 158,874 | 190,786 |
| Right-of-use assets – operating | 52,204 | 54,873 |
| Goodwill | 99,720 | 60,176 |
| Intangibles, net | 116,230 | 108,363 |
| Deferred tax asset, net | 102,375 | 134,540 |
| Other long-term assets | 10,857 | 7,354 |
| Total noncurrent assets | 540,260 | 556,092 |
| Total assets | $1,268,307 | $1,197,483 |
| Liabilities and stockholders’ equity | ||
| Current liabilities | ||
| Accounts payable | $60,711 | $65,201 |
| Accrued expenses | 49,148 | 60,593 |
| Operating lease liabilities | 12,670 | 10,547 |
| Contract liabilities | 11,986 | 13,463 |
| Current portion of long-term debt and finance lease obligations | 6,709 | 10,467 |
| Other current liabilities | 6,940 | 2,387 |
| Total current liabilities | 148,164 | 162,658 |
| Noncurrent liabilities | ||
| Long-term debt and finance lease obligations | 18,922 | 24,901 |
| Operating lease liabilities | 40,986 | 45,153 |
| Deferred income taxes | 500 | 624 |
| Other long-term liabilities | 2,036 | 5,991 |
| Total noncurrent liabilities | 62,444 | 76,669 |
| Total liabilities | $210,608 | $239,327 |
| Commitments and contingencies (Note 16) | ||
| Stockholders’ equity | ||
| Preferred stock: 10,000,000 shares authorized at $0.01 par value (none issued) | $— | $— |
| Common stock: $0.01 par value, 200,000,000 and 100,000,000 shares authorized at December 31, 2025 and December 31, 2024, respectively; 69,077,237 and 69,178,263 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 691 | 692 |
| Additional paid-in capital | 767,650 | 755,077 |
| Accumulated other comprehensive income (loss) | 4,084 | (8,863) |
| Retained earnings | 285,274 | 211,250 |
| Total stockholders’ equity | $1,057,699 | $958,156 |
| Total liabilities and stockholders’ equity | $1,268,307 | $1,197,483 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.